TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 64 filers reported holding TREVI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $101 | -17.2% | 33,915 | -3.6% | 0.00% | – |
Q1 2024 | $122 | +41.9% | 35,195 | -44.8% | 0.00% | – |
Q4 2023 | $86 | +196.6% | 63,797 | +380.2% | 0.00% | – |
Q3 2023 | $29 | -14.7% | 13,285 | -5.5% | 0.00% | – |
Q2 2023 | $34 | – | 14,052 | +13952.0% | 0.00% | – |
Q3 2021 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2021 | $0 | – | 100 | +566.7% | 0.00% | – |
Q2 2020 | $0 | – | 15 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 11,370,376 | $27,175,199 | 2.07% |
Fairmount Funds Management LLC | 5,190,360 | $12,404,960 | 1.75% |
VR Adviser, LLC | 3,422,397 | $8,179,529 | 1.31% |
Frazier Life Sciences Management, L.P. | 6,881,090 | $16,445,805 | 0.98% |
Opaleye Management Inc. | 1,701,500 | $4,066,585 | 0.97% |
SILVERARC CAPITAL MANAGEMENT, LLC | 885,924 | $2,117,358 | 0.66% |
Rubric Capital Management LP | 5,684,420 | $13,585,764 | 0.58% |
Tejara Capital Ltd | 180,227 | $430,743 | 0.21% |
PFS Partners, LLC | 100,000 | $239,000 | 0.20% |
WealthTrust Axiom LLC | 93,500 | $223,465 | 0.07% |